Salubris Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Salubris Biotherapeutics's estimated annual revenue is currently $3.2M per year.
- Salubris Biotherapeutics's estimated revenue per employee is $77,500
- Salubris Biotherapeutics's total funding is $67M.
Employee Data
- Salubris Biotherapeutics has 41 Employees.
- Salubris Biotherapeutics grew their employee count by 0% last year.
Salubris Biotherapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | SVP & Head Oncology | Reveal Email/Phone |
2 | VP, Clinical Development | Reveal Email/Phone |
3 | VP Clinical Development | Reveal Email/Phone |
4 | SVP, Oncology Clinical Lead | Reveal Email/Phone |
5 | Director | Reveal Email/Phone |
6 | Associate Director Clinical Operations | Reveal Email/Phone |
7 | Human Resources Director | Reveal Email/Phone |
8 | Chief Scientific Officer | Reveal Email/Phone |
9 | Director, CMC | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
Salubris Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | 0% | N/A | N/A |
#2 | $3.6M | 46 | -31% | $17.5M | N/A |
#3 | $3.6M | 46 | -34% | $10.5M | N/A |
#4 | $30.2M | 156 | 0% | $69.4M | N/A |
#5 | $11.8M | 76 | -15% | N/A | N/A |
#6 | $1.7M | 11 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $8.8M | 57 | 19% | N/A | N/A |
#9 | $0.2M | 1 | -86% | N/A | N/A |
#10 | $2M | 13 | 18% | N/A | N/A |
What Is Salubris Biotherapeutics?
SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com). SalubrisBio is an innovation-focused biotech with pioneering research and development programs. Headquartered in Gaithersburg, Maryland, SalubrisBio represents and reflects Salubris Pharmaceuticals’ commitment to innovation and expansion into the global market. SalubrisBio focuses exclusively on the discovery and global development of novel, biologic therapeutics. Salubris Pharmaceuticals is a publicly-traded company [002294:CH], founded in 1998, which has grown to achieve sales of >$750M USD in 2016. Salubris Pharmaceuticals is a fully-integrated drug development company. Headquartered in Shenzhen, China, Salubris Pharmaceuticals has over 3,000 employees working across R&D, regulatory, marketing and sales. Its marketed products include small molecule drugs in the cardiovascular, anti-allergy and anti-infective therapeutic areas. GeneKey Biotech Ltd. Co. (www.genekeybio.com), based in Chengdu, China, is the China-based biologics subsidiary of Salubris Pharmaceuticals. GeneKey Biotech has a robust portfolio of biosimilar and novel large molecule therapeutics in development in China. SalubrisBio maintains close cross-functional collaborations with GeneKey Biotech, leveraging resources including the expertise of >150 research scientists and large-scale manufacturing of up to 2000L scale.
keywords:N/A
$67M
Total Funding
41
Number of Employees
$3.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Gaithersburg
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.8M | 41 | 8% | N/A |
#2 | $9.5M | 41 | -18% | N/A |
#3 | $11.1M | 43 | -4% | N/A |
#4 | $10M | 43 | 13% | N/A |
#5 | $6M | 43 | 0% | N/A |